HomeAI · summaries
Storia in 6 fonti
Why Is Abivax Stock Skyrocketing Tuesday? - Abivax (NASDAQ:ABVX)
Abivax (ABVX) stock skyrockets 36% following strong Phase 3 maintenance data for its ulcerative colitis treatment. Get the latest details.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Abivax seeks to ease safety concerns with new data, boosting shares
Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago. But a new analysis sent them climbing.
- ·
cnbc.com
French biotech stock soars 25% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
